Hall Laurie J Trustee lifted its holdings in Medtronic PLC (NYSE:MDT) by 4.3% in the 1st quarter, HoldingsChannel reports. The firm owned 4,549 shares of the medical technology company’s stock after purchasing an additional 189 shares during the quarter. Hall Laurie J Trustee’s holdings in Medtronic were worth $414,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in the company. Cordasco Financial Network bought a new position in Medtronic during the first quarter valued at about $27,000. Tributary Capital Management LLC purchased a new stake in shares of Medtronic during the fourth quarter valued at $27,000. Pin Oak Investment Advisors Inc. lifted its holdings in shares of Medtronic by 158.0% during the fourth quarter. Pin Oak Investment Advisors Inc. now owns 369 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 226 shares during the last quarter. Highwater Wealth Management LLC purchased a new stake in shares of Medtronic during the fourth quarter valued at $39,000. Finally, Spectrum Management Group Inc. lifted its holdings in shares of Medtronic by 353.8% during the first quarter. Spectrum Management Group Inc. now owns 413 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 322 shares during the last quarter. 81.52% of the stock is owned by institutional investors.

Several brokerages have recently commented on MDT. Zacks Investment Research downgraded Medtronic from a “hold” rating to a “sell” rating in a report on Tuesday, April 30th. Wells Fargo & Co reduced their target price on Medtronic from $101.00 to $100.00 and set a “market perform” rating for the company in a report on Thursday, April 4th. Northland Securities reaffirmed a “hold” rating and set a $84.00 target price on shares of Medtronic in a report on Monday, March 18th. Citigroup upped their target price on Medtronic from $95.00 to $101.00 and gave the company a “neutral” rating in a report on Monday, February 25th. Finally, Barclays reaffirmed a “buy” rating and set a $104.00 target price on shares of Medtronic in a report on Wednesday, February 20th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Medtronic has a consensus rating of “Buy” and a consensus target price of $103.39.

Shares of Medtronic stock opened at $87.66 on Thursday. The stock has a market capitalization of $117.32 billion, a P/E ratio of 18.38, a price-to-earnings-growth ratio of 2.17 and a beta of 0.78. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.36 and a quick ratio of 1.92. Medtronic PLC has a 1 year low of $81.66 and a 1 year high of $100.15.

Medtronic (NYSE:MDT) last announced its quarterly earnings data on Tuesday, February 19th. The medical technology company reported $1.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.05. The firm had revenue of $7.55 billion during the quarter, compared to the consensus estimate of $7.53 billion. Medtronic had a return on equity of 13.85% and a net margin of 16.10%. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.17 EPS. On average, research analysts forecast that Medtronic PLC will post 5.15 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Medtronic PLC (MDT) Stake Lifted by Hall Laurie J Trustee” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2019/05/16/medtronic-plc-mdt-stake-lifted-by-hall-laurie-j-trustee.html.

About Medtronic

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

Read More: Bear Market – How and Why They Occur

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.